Davenport & Co’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-50,750
| Closed | -$262K | – | 779 |
|
|
2019
Q3 | $262K | Hold |
50,750
| – | – | ﹤0.01% | 594 |
|
|
2019
Q2 | $262K | Sell |
50,750
-35,500
| -41% | -$183K | ﹤0.01% | 595 |
|
|
2019
Q1 | $311K | Sell |
86,250
-5,000
| -5% | -$18K | ﹤0.01% | 529 |
|
|
2018
Q4 | $559K | Sell |
91,250
-42,000
| -32% | -$257K | 0.01% | 378 |
|
|
2018
Q3 | $778K | Sell |
133,250
-11,500
| -8% | -$67.1K | 0.01% | 353 |
|
|
2018
Q2 | $615K | Sell |
144,750
-28,378
| -16% | -$121K | 0.01% | 399 |
|
|
2018
Q1 | $763K | Sell |
173,128
-3,872
| -2% | -$17.1K | 0.01% | 361 |
|
|
2017
Q4 | $931K | Sell |
177,000
-1,000
| -0.6% | -$5.26K | 0.01% | 329 |
|
|
2017
Q3 | $1.09M | Buy |
178,000
+106,000
| +147% | +$650K | 0.01% | 294 |
|
|
2017
Q2 | $521K | Buy |
+72,000
| New | +$521K | 0.01% | 416 |
|